SMSarah Millot

Sarah Millot

*This is an algorithmically generated author record based on publicly available information.

Sarah Millot has a total of 96 co-authors. Here are the top co-authors by number of shared publications:

  • Carole Beaumont

    INSERM U1149/ERL CNRS 8252, Centre de Recherche sur l’Inflammation Paris Montmartre, 75018 Paris, France

    5 shared publications
  • Zoubida Karim

    Université de Toulouse, INSERM, Centre National de la Recherche Scientifique, Institut Toulousain des Maladies Infectieuses et Inflammatoires (Infinity), Université Paul Sabatier, Toulouse, France

    4 shared publications
  • Hervé Puy

    Laboratory of Excellence GR-Ex, Paris, France

    3 shared publications
  • Jean-Luc Charrier

    Department of oral surgery, Bretonneau hospital, AP-HP, university of Paris Descartes, 75018 Paris, France

    3 shared publications
  • Laurent Gouya

    INSERM U773, Centre de Recherche Biomédicale Bichat Beaujon CRB3, Université Paris 7 Denis Diderot, site Bichat, Paris, France

    3 shared publications
  • Philippe Lettéron

    INSERM U1149/ERL CNRS 8252, Centre de Recherche sur l’Inflammation Paris Montmartre, 75018 Paris, France

    3 shared publications

Latest Publications

  • Bactériémie et orthodontie : conduite à tenir avec et sans facteur de risque d’endocardite infectieuse

    by Claire Divry, Sarah Millot-Guard, Sarah Gebeile-Chauty

    Cases of focal oral bacterial infections - including infective endocarditis - have been reported during orthodontic treatment in patients with no previous medical history. This raises the question of whether orthodontic treatment is responsible for the development of these infections. The aim of this narrative literature review was to determine whether or not bacteremia, directly or indirectly related to orthodontic treatment, is present and what precautions should be taken in orthodontic treatment of patients with and without risk of infective endocarditis. A narrative literature review was carried out using two keyword searches on PubMed. Transient bacteremia may occur during everyday activities and dental procedures. This bacteremia is influenced by factors linked to the invasiveness of the procedure and the patient's periodontal indices. In patients at risk of infective endocarditis, the new French professional recommendations do not contraindicate any orthodontic procedure. In patients at high risk of infective endocarditis, stripping, corticotomies, orthodontic exposure of impacted teeth, and insertion and removal of bone anchors require antibiotic prophylaxis. The following procedures are contraindicated in these patients: pulpectomy of temporary teeth, pulp capping of mature permanent teeth, use of bone regeneration membranes, and conservative treatment of peri-implantitis. Any procedure, whether therapeutic or not, generates bacteremia, which is often minimal and depends on the procedures performed. Orthodontic appliances, because of the length of time they are worn and the difficulty of maintaining good oral hygiene, are likely to generate an additional bacteremia which, in principle, should have no consequences in a healthy patient. Although orthodontic procedures are relatively frequent, studies are rare and often have a low level of evidence. The role of the orthodontist is to identify the patient's level of risk, to educate and motivate the patient in oral hygiene, and to apply the precautionary measures set out in the new HAS recommendations for patients at risk of infective endocarditis.

  • Open Access

    Novel guidelines for the dental management of patients at risk of Infective Endocarditis in France

    by Sarah Millot

    Journal of Oral Medicine and Oral Surgery revue de la SFCO. Elle est consacrée à l étude et au traitement des affections de la cavité buccale, ainsi qu à la formation continue, à la recherche et aux progrès techniques et scientifiques

  • Open Access

    Patients with Obstructive Sleep Apnea and Cardiovascular Diseases: What, When, and Why Is Mandibular Advancement Device Treatment Required? A Short Review

    by Cindy François, Arthur Bonafé, Camille Roubille, François Roubille, Isabelle Dupuy-Bonafé, Sarah Millot

    Obstructive sleep apnea is a potentially dangerous condition with significant risks of comorbidities if left untreated. It represents a cardiovascular risk factor in the general population, and a higher prevalence is observed in patients already suffering from cardiovascular diseases. The gold standard treatment, continuous positive airway pressure, is not always accepted or tolerated. The mandibular advancement device represents an alternative treatment that we propose to implement in our study. The objective here is to first present a brief review of the topic. Due to poor evidence in the field, we propose a pilot study to evaluate the effect of a mandibular advancement device in patients with cardiovascular disease who are not treated for their sleep pathology in order to improve their therapeutic management.


  • Open Access

    Dental procedures, antibiotic prophylaxis, and endocarditis among people with prosthetic heart valves: nationwide population based cohort and a case crossover study

    by Sarah Tubiana, Pierre-Olivier Blotière, Bruno Hoen, Philippe Lesclous, Sarah Millot, Jérémie Rudant, Alain Weill, Joel Coste, François Alla, Xavier Duval

    Objective To assess the relation between invasive dental procedures and infective endocarditis associated with oral streptococci among people with prosthetic heart valves. Design Nationwide population based cohort and a case crossover study. Setting French national health insurance administrative data linked with the national hospital discharge database. Participants All adults aged more than 18 years, living in France, with medical procedure codes for positioning or replacement of prosthetic heart valves between July 2008 and July 2014. Main outcome measures Oral streptococcal infective endocarditis was identified using primary discharge diagnosis codes. In the cohort study, Poisson regression models were performed to estimate the rate of oral streptococcal infective endocarditis during the three month period after invasive dental procedures compared with non-exposure periods. In the case crossover study, conditional logistic regression models calculated the odds ratio and 95% confidence intervals comparing exposure to invasive dental procedures during the three month period preceding oral streptococcal infective endocarditis (case period) with three earlier control periods. Results The cohort included 138 876 adults with prosthetic heart valves (285 034 person years); 69 303 (49.9%) underwent at least one dental procedure. Among the 396 615 dental procedures performed, 103 463 (26.0%) were invasive and therefore presented an indication for antibiotic prophylaxis, which was performed in 52 280 (50.1%). With a median follow-up of 1.7 years, 267 people developed infective endocarditis associated with oral streptococci (incidence rate 93.7 per 100 000 person years, 95% confidence interval 82.4 to 104.9). Compared with non-exposure periods, no statistically significant increased rate of oral streptococcal infective endocarditis was observed during the three months after an invasive dental procedure (relative rate 1.25, 95% confidence interval 0.82 to 1.82; P=0.26) and after an invasive dental procedure without antibiotic prophylaxis (1.57, 0.90 to 2.53; P=0.08). In the case crossover analysis, exposure to invasive dental procedures was more frequent during case periods than during matched control periods (5.1% v 3.2%; odds ratio 1.66, 95% confidence interval 1.05 to 2.63; P=0.03). Conclusion Invasive dental procedures may contribute to the development of infective endocarditis in adults with prosthetic heart valves.


  • Oral Streptococcal Endocarditis, Oral Hygiene Habits, and Recent Dental Procedures: A Case-Control Study

    by Xavier Duval, Sarah Millot, Catherine Chirouze, Christine Selton-Suty, Vanessa Moby, Pierre Tattevin, Christophe Strady, Edouard Euvrard, Nelly Agrinier, Daniel Thomas, et al.

    We aimed to compare oral hygiene habits, orodental status, and dental procedures in patients with infective endocarditis (IE) according to whether the IE-causing microorganism originated in the oral cavity. We conducted an assessor-blinded case-control study in 6 French tertiary-care hospitals. Oral hygiene habits were recorded using a self-administered questionnaire. Orodental status was analyzed by trained dental practitioners blinded to the microorganism, using standardized clinical examination and dental panoramic tomography. History of dental procedures was obtained through patient and dentist interviews. Microorganisms were categorized as oral streptococci or nonoral pathogens using an expert-validated list kept confidential during the course of the study. Cases and controls had definite IE caused either by oral streptococci or nonoral pathogens, respectively. Participants were enrolled between May 2008 and January 2013. Cases (n = 73) were more likely than controls (n = 192) to be aged <65 years (odds ratio [OR], 2.85; 95% CI, 1.41–5.76), to be female (OR, 2.62; 95% CI, 1.20–5.74), to have native valve disease (OR, 2.44; 95% CI, 1.16–5.13), to use toothpicks, dental water jet, interdental brush, and/or dental floss (OR, 3.48; 95% CI, 1.30–9.32), and to have had dental procedures during the prior 3 months (OR, 3.31; 95% CI, 1.18–9.29), whereas they were less likely to brush teeth after meals. The presence of gingival inflammation, calculus, and infectious dental diseases did not significantly differ between groups. Patients with IE caused by oral streptococci differ from patients with IE caused by nonoral pathogens regarding background characteristics, oral hygiene habits, and recent dental procedures, but not current orodental status.


  • Open Access

    Osteomyelitis of the Mandible after Dental Implants in an Immunocompetent Patient

    by Matthieu Balanger, Margaux Hinet, Christian Vacher, Norbert Bellaiche, Jean-Luc Charrier, Sarah Millot

    Dental implants are now broadly used to replace missing teeth, and the presence of infectious complications is rising. Dental implant therapy as a local risk factor for the onset of osteomyelitis and its management have not been widely explored. Here, we report an unusual case of mandibular suppurative osteomyelitis caused by Streptococcus intermedius in a healthy and immunocompetent patient secondary to mandibular implants. We describe how surgery combined with systemic application of antibiotics allowed conservation of the dental implants in the mandibular bone, discuss the probable source of contamination, and present the follow‐up of the osteomyelitis.


  • Open Access

    Hemolytic anemia repressed hepcidin level without hepatocyte iron overload: lesson from Günther disease model

    by Sarah Millot, Constance Delaby, Boualem Moulouel, Thibaud Lefebvre, Nathalie Pilard, Nicolas Ducrot, Cécile Ged, Philippe Lettéron, Lucia de Franceschi, Jean Charles Deybach, et al.

    Hemolysis occuring in hematologic diseases is often associated with an iron loading anemia. This iron overload results from a massive outflow of hemoglobin (Hb) in the bloodstream, but the mechanism of Hb handling is not fully elucidated. Here, we evaluate in a congenital erythropoietic porphyria mouse model the impact of hemolysis and regenerative anemia on hepcidin synthesis and iron metabolism. The hemolysis was confirmed by a complete drop in haptoglobin, hemopexin and increased plasma LDH, an increased RBC Distribution Width and osmotic fragility, a reduced half-life of RBCs, and increased expression of heme oxygenase 1 (HO-1). The erythropoiesis-induced Fam132b was increased, hepcidin mRNA repressed, and transepithelial iron transport in isolated duodenal loops increased. Iron was mostly accumulated in liver and spleen macrophages but transferrin saturation remained at normal range. The expression levels of CD163 (Hb-haptoglobin receptor) and CD91 (Hemopexin receptor) were drastically reduced in both liver and spleen, resulting in heme- and Hb-derived iron elimination in urine. In the kidney, the megalin/cubilin endocytic complex; HO-1 and the iron exporter ferroportin were induced, which is reminiscent of significant renal handling of Hb-derived iron. Our results highlight ironbound Hb urinary clearance mechanism and strongly suggest that, in addition to the sequestration of iron in macrophages, kidney may play a major role to protect hepatocytes from iron overload in chronic hemolysis


  • Hepcidin as a Major Component of Renal Antibacterial Defenses against Uropathogenic Escherichia coli

    by Dounia Houamel, Nicolas Ducrot, Thibaud Lefebvre, Raed Daher, Boualem Moulouel, Marie-Agnes Sari, Philippe Letteron, Said Lyoumi, Sarah Millot, Jerome Tourret, et al.

    The iron-regulatory peptide hepcidin exhibits antimicrobial activity. Having previously shown hepcidin expression in the kidney, we addressed its role in urinary tract infection (UTI), which remains largely unknown. Experimental UTI was induced in wild-type (WT) and hepcidin-knockout (Hepc−/−) mice using the uropathogenic Escherichia coli CFT073 strain. Compared with infected WT mice, infected Hepc−/− mice showed a dramatic increase in renal bacterial load. Moreover, bacterial invasion was significantly dampened by the pretreatment of WT mice with hepcidin. Infected Hepc−/− mice exhibited decreased iron accumulation in the renal medulla and significant attenuation of the renal inflammatory response. Notably, we demonstrated in vitro bacteriostatic activity of hepcidin against CFT073. Furthermore, CFT073 repressed renal hepcidin, both in vivo and in cultured renal cells, and reduced phosphorylation of SMAD kinase in vivo, suggesting a bacterial strategy to escape the antimicrobial activities of hepcidin. In conclusion, we provide new mechanisms by which hepcidin contributes to renal host defense and suggest that targeting hepcidin offers a strategy to prevent bacterial invasion.


  • Efficacy and toxicity of intravenous iron in a mouse model of critical care anemia*

    by Nicholas Heming, Philippe Lettéron, Fathi Driss, Sarah Millot, Jamel El Benna, Jérome Tourret, Erick Denamur, Philippe Montravers, Carole Beaumont, Sigismond Lasocki

    Objective: Anemia is common in critically ill patients, due to inflammation and blood loss. Anemia can be associated with iron deficiency and low serum hepcidin levels. However, iron administration in this setting remains controversial because of its potential toxicity, including oxidative stress induction and sepsis facilitation. The objective of this work was to determine the efficacy and toxicity of iron administration using a mouse model mimicking critical care anemia as well as a model of acute septicemia. Design: Prospective, randomized, open label controlled animal study. Setting: University-based research laboratory. Subjects: C57BL/6 and OF1 mice. Interventions: Intraperitoneal injection of zymosan inducing generalized inflammation in C57BL/6 mice, followed in our full model by repeated phlebotomies. A dose equivalent to 15 mg/kg of ferric carboxymaltose was injected intravenously on day 5. To assess the toxicity of iron in a septicemia model, OF1 mice were simultaneously injected with iron and different Escherichia coli strains. Measurements and Main Results: To investigate the effect of iron on oxidative stress, we measured reactive oxygen species production in the blood using luminol-amplified chemiluminescence and superoxide dismutase 2 messenger RNA levels in the liver. These markers of oxidative stress were increased after iron administration in control mice but not in zymosan-treated mice. Liver catalase messenger RNA levels decreased in iron-treated control mice. Iron administration was not associated with increased mortality in the septicemia model or in the generalized inflammation model. Iron increased hemoglobin levels in mice fed with a low iron diet and subjected to phlebotomies and zymosan 2 wks after treatment administration. Conclusions: Adverse effects of intravenous iron supplementation by ferric carboxymaltose seem to be minimal in our animal models. Furthermore, iron appears to be effective in correcting anemia, despite inflammation. Studies of efficacy and safety of iron in critically ill patients are warranted.